The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems. Are there any new Parkinson's drugs which are safer for patients with heart risks?
| Publié dans: | Heart advisor. - 1999. - 12(2009), 8 vom: 18. Aug., Seite 8 |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
2009
|
| Accès à la collection: | Heart advisor |
| Sujets: | Journal Article Antiparkinson Agents Dopamine Agonists Ergolines Pergolide 24MJ822NZ9 Cabergoline LL60K9J05T |